Hsin Yang Liu

Corporate Officer/Principal at TSH BIOPHARM CORPORATION LIMITED

Health Technology

Consumer Services

Profile

Hsin Yang Liu is currently the Vice General Manager-General Administration at TSH Biopharm Corp., Ltd.
Previously, she held the position of VP-Administrative, Director-Accounting & Finance at Body Organ Biomedical Corp.
in 2012.
She also served as a Member-Supervisory Board at Reber Genetics Co., Ltd.
Dr. Liu completed her undergraduate and graduate degrees at National Taiwan University and obtained a doctorate degree from Nankai University.

Hsin Yang Liu active positions

Companies	Position	Start
TSH BIOPHARM CORPORATION LIMITED	Corporate Officer/Principal	-

All active positions of Hsin Yang Liu

Former positions of Hsin Yang Liu

Companies	Position	End
REBER GENETICS CO LTD	Director/Board Member	-
BODY ORGAN BIOMEDICAL CORP	Director of Finance/CFO	-

See the detail of Hsin Yang Liu's experience

Training of Hsin Yang Liu

National Taiwan University	Graduate Degree
Nankai University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hsin Yang Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
TSH BIOPHARM CORPORATION LIMITED	Health Technology

Private companies	2
Body Organ Biomedical Corp. Body Organ Biomedical Corp. BiotechnologyHealth Technology Body Organ Biomedical Corp. engages in the research, development, manufacture and sales of biomedical devices. It also provides regenerative solutions to restore tissue damage in orthopedics, dentistry, ophthalmology, reconstructive and general surgery. The company was founded on May 4, 2007 and is headquartered in Taipei, Taiwan.	Health Technology
Reber Genetics Co., Ltd. Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan.	Health Technology

Private companies